Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement of the GLP-1 Pathway

Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638

Decoding the Patterns of Self and Nonself by the Innate Immune System

Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154

Glucagon-like peptide-1 7–36: a physiological incretin in man

Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297

Stress-induced hyperglycemia

McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170

Hypoglycemia and risk of death in critically ill patients

The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793

Bacterial Endotoxin Is an Active Component of Cigarette Smoke

Hasday, J. D., Bascom, R., Costa, J. J., Fitzgerald, T., & Dubin, W. (1999) · CHEST Journal · doi:10.1378/chest.115.3.829 · Cited by 388

Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans

Mehta, N. N., McGillicuddy, F. C., Anderson, P. D., Hinkle, C. C., Shah, R. D., Pruscino, L., Tabita‐Martinez, J., Sellers, K. F., Rickels, M. R., & Reilly, M. P. (2009) · Diabetes · doi:10.2337/db09-0367 · Cited by 354

Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency

Jiang, X.-C., Qin, S., Qiao, C., Kawano, K., Lin, M., Skold, A., Xiao, X., & Tall, A. R. (2001) · Nature Medicine · doi:10.1038/89977 · Cited by 256

Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance

Caradonna, L., Amati, L., Magrone, T., Pellegrino, N. M., Jirillo, E., & Caccavo, D. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060030101 · Cited by 247

Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide

Rouillé, Y., Martin, S., & Steiner, D. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26488 · Cited by 245

Enteroendocrine cells express functional Toll-like receptors

Bogunovic, M., Davé, S. H., Tilstra, J. S., Chang, D. T. W., Harpaz, N., Xiong, H., Mayer, L. F., & Plevy, S. E. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00249.2006 · Cited by 230

Insulin Resistance and Substrate Utilization in Human Endotoxemia

Agwunobi, A. O., Reid, C. L., Maycock, P. F., Little, R. A., & Carlson, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6914 · Cited by 229

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.

Harris, H. W., Grünfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214

Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide

Cavaillon, J., Fitting, C., Haeffner‐Cavaillon, N., Kirsch, S. J., & Warren, H. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2375-2382.1990 · Cited by 186

Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells

Vives‐Pi, M., Somoza, N., Fernández-Álvarez, J., Vargas, F., CARO, P., ALBA, A., Gomis, R., Labéta, M. O., & Pujol‐Borrell, R. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02211.x · Cited by 148

Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins

Flegel, W. A., Wolpl, A., Männel, D. N., & Northoff, H. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2237-2245.1989 · Cited by 148

Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine.

Drucker, D. J., & BRUBAKER, P. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.3953 · Cited by 135

Glucagon‐like peptide 1: A potent glycogenic hormone

Valverde, I., Morales, M., Clemente, F., López-Delgado, M. I., Delgado, E., Perea, A., & Villanueva‐Peñacarrillo, M. L. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00699-7 · Cited by 134

Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance

Caradonna, L., Amati, L., Magrone, T., Pellegrino, N. M., Jirillo, E., & Caccavo, D. (2000) · Journal of Endotoxin Research · doi:10.1179/096805100101532063 · Cited by 120

Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

Xiao, Q., Boushey, R. P., Cino, M., Drucker, D. J., & Brubaker, P. L. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.4.r1057 · Cited by 111

Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo

Attané, C., Daviaud, D., Dray, C., Dusaulcy, R., Masseboeuf, M., Prévot, D., Carpéné, C., Castan‐Laurell, I., & Valet, P. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0105 · Cited by 109

Blood glucose control in patients with severe sepsis and septic shock

Hirasawa, H., Oda, S., & Nakamura, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4132 · Cited by 109

Insulin-mediated glucose uptake by individual tissues during sepsis

Lang, C. H., Dobrescu, C., & Mészáros, K. (1990) · Metabolism · doi:10.1016/0026-0495(90)90172-9 · Cited by 102

Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis

Garay-Malpartida, M., Mourão, R. F., Mantovani, M. D. C., Santos, I. D. A., Sogayar, M. C., & Goldberg, A. C. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-18 · Cited by 94

Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1

IDRIS, I. R., Patiag, D., Gray, S., & Donnelly, R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00924-8 · Cited by 87

Lipopolysaccharide inhibition of glucose production through the Toll‐like receptor‐4, myeloid differentiation factor 88, and nuclear factor κb pathway†

Raetzsch, C. F., Brooks, N. L., Alderman, J. M., Moore, K. S., Hosick, P. A., Klebanov, S., Akira, S., Bear, J. E., Baldwin, A. S., Mackman, N., et al. (2009) · Hepatology · doi:10.1002/hep.22999 · Cited by 77

Early Endotoxemia Increases Peripheral and Hepatic Insulin Sensitivity in Healthy Humans

van der Crabben, S. N., Blümer, R. M. E., Stegenga, M. E., Ackermans, M. T., Endert, E., Tanck, M. W. T., Serlie, M. J. M., van der Poll, T., & Sauerwein, H. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0761 · Cited by 77

Effect of Plasma Phospholipid Transfer Protein Deficiency on Lethal Endotoxemia in Mice

Gautier, T., Klein, A., Deckert, V., Desrumaux, C. M., Ogier, N., Sberna, A.-L., Paul, C., Guern, N. L., Athias, A., Montange, T., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802802200 · Cited by 69

Increased insulin resistance and β cell activity in patients with Crohnʼs disease

Bregenzer, N., Hartmann, A., Strauch, U., Schölmerich, J., Andus, T., & Bollheimer, C. L. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195975.97673.f5 · Cited by 66

Enteroendocrine cells in terminal ileal Crohn's disease

Moran, G. W., Pennock, J. L., & McLaughlin, J. T. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.01.013 · Cited by 61

Insulin Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B (Akt) Pathway Reduces Lipopolysaccharide-Induced Inflammation in Mice

Kidd, L. B., Schabbauer, G., Luyendyk, J. P., Holscher, T. D., Tilley, R. E., Tencati, M., & Mackman, N. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138891 · Cited by 57

Lipopolysaccharide induces calcitonin gene‐related peptide in the RAW264.7 macrophage cell line

Ma, W., Dumont, Y., Vercauteren, F., & Quirion, R. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03239.x · Cited by 57

Effect of high-dose endotoxin on glucose production and utilization

Lang, C. H., Spolarics, Z., Ottlakán, A., & Spitzer, J. J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90137-d · Cited by 50

Dipeptidyl peptidase-4 expression is reduced in Crohn's disease

Moran, G. W., O’Neill, C. A., Padfield, P. J., & McLaughlin, J. T. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.04.006 · Cited by 46

Sitagliptin: a review

SUBBARAYAN, S. K., & Kipnes, M. S. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.580738 · Cited by 46

Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages

Vindrola, O., Mayer, A. M. S., Citera, G., Spitzer, J. A., & Espinoza, L. R. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90004-3 · Cited by 43

Hyperglycemia in the Intensive Care Unit: No Longer Just a Marker of Illness Severity

Taylor, J. H., & Beilman, G. J. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.233 · Cited by 38

Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen

Lansac, G., Dong, W., Dubois, C. M., Larbi, N. B., Afonso, C., Fournier, I., Salzet, M., & Day, R. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.019 · Cited by 38

Hyperinsulinism in endotoxin shock dogs

Blackard, W. G., Anderson, J. H., & Spitzer, J. J. (1976) · Metabolism · doi:10.1016/0026-0495(76)90065-2 · Cited by 35

Endotoxin-enhanced secretion of macrophage insulin-like activity.

Filkins, J. P. (1980) · PubMed · Cited by 35

Increased muscle glucose uptake and lactate release after endotoxin administration

Romanosky, A. J., Bagby, G. J., Bockman, E. L., & Spitzer, J. J. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.239.5.e311 · Cited by 35

Metabolic response to endotoxin in vivo in the conscious mouse: role of interleukin-6

Tweedell, A. D., Mulligan, K. X., Martel, J. E., Chueh, F., Santomango, T. S., & McGuinness, O. P. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.022 · Cited by 34

Effects of Acute Endotoxemia on Glucoregulation in Normal and Diabetic Subjects

Rayfield, E. J., Curnow, R. T., REINHARD, D., & KOCHICHERIL, N. M. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-513 · Cited by 30

Lipopolysaccharide-induced sensitization of adenylyl cyclase activity in murine macrophages

Osawa, Y., Lee, H. T., Hirshman, C. A., Xu, D., & Emala, C. W. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00171.2005 · Cited by 28

Enhanced glucose‐dependent glucagon‐like peptide‐1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection

Bendet, N., Scapa, E. F., Cohen, O., Bloch, O., Aharoni, D., Ramot, Y., Weiss, M., Halevi, A., & Rapoport, M. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004839 · Cited by 26

Mechanism of hyperinsulinemia in endotoxicosis

Yelich, M. R., & Filkins, J. P. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.239.2.e156 · Cited by 25

Insulin hypersecretion and potentiation of endotoxin shock in the rat.

Yelich, M. R., & Filkins, J. P. (1982) · PubMed · Cited by 22

Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum

Herrmann-Rinke, C., McGregor, G. P., & Göke, B. (2000) · Peptides · doi:10.1016/s0196-9781(00)00167-4 · Cited by 21

Toll-like receptor 4-mediated cAMP production up-regulates B-cell activating factor expression in Raw264.7 macrophages

Moon, E., Lee, Y., Choi, W. S., & Lee, M.-H. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.003 · Cited by 20

Metabolic and hormonal changes following endotoxin administration to diabetic rats

Kelleher, D. L., Fong, B. C., Bagby, G. J., & Spitzer, J. J. (1982) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1982.243.1.r77 · Cited by 19

Exdotoxin-induced metabolic changes in the conscious, unrestrained rat: hypoglycemia and elevated blood lactate concentrations without hyperinsulinemia.

Ga, A., Al‐Jibouri, L. M., Bl, F., & Parratt, J. R. (1981) · PubMed · Cited by 13

Hyperinsulinemia elicited by interleukin-1 and nonlethal endotoxemia in rats.

Cornell, R. (1989) · PubMed · Cited by 12

Insulin-like action of endotoxin: antagonism by steroidal and nonsteroidal anti-inflammatory agents.

Witek‐Janusek, L., & Filkins, J. P. (1981) · PubMed · Cited by 10

Effects of toxic and nontoxic endotoxin derivatives on glucose kinetics.

Lang, C. H., Gj, B., Nowotny, A., & Spitzer, J. J. (1985) · PubMed · Cited by 10

The potential impact of admission insulin levels on patient outcome in the intensive care unit

Rosa, G. D. L., Vasquez, E. M., Quintero, A., Donado, J., Marisol Bedoya, A., Restrepo, A. H., Roncancio, G. E., Cadavid, C. A., & Jaimes, F. A. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3182788042 · Cited by 9

Role for calcium in the insulin hypersecretory state of the endotoxic rat pancreas.

Mr, Y., & Filkins, J. P. (1984) · PubMed · Cited by 8

Relation of endotoxin structure to hypoglycemic and insulinlike actions.

Witek‐Janusek, L., & Filkins, J. P. (1983) · PubMed · Cited by 8

Involvement of capsaicin-sensitive nerves in regulating the hormone and glucose metabolic response to endotoxin

Morgan, A. E., & Lang, C. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e328 · Cited by 7

Increased glucose uptake precedes hyperinsulinemia in awake endotoxemic minipigs.

Hand, M. S., Mj, F., Lg, C., Cleek, J. L., Mason, R. A., & Phillips, R. W. (1983) · PubMed · Cited by 6

Altered glucose kinetics in diabetic rats during gram-negative infection

Lang, C. H., Dobrescu, C., Bagby, G. J., & Spitzer, J. J. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.253.2.e123 · Cited by 4

Insulin response to continuous glucose load in endotoxin shock in the dog.

Manny, J., Rabinovici, N., & Schiller, M. (1977) · PubMed · Cited by 4

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170

Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium

Gribble, F. M., & Reimann, F. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105439 · Cited by 683

The Cardiovascular Biology of Glucagon-like Peptide-1

Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665

The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release

Martin, A. M., Sun, E. W. L., Rogers, G. B., & Keating, D. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00428 · Cited by 402

Lipopolysaccharides-Mediated Increase in Glucose-Stimulated Insulin Secretion: Involvement

Pathway, O. T. G. (2016)

P216: Augmentation par les Lipopolysaccharides de la sécrétion d’insuline stimulée par le glucose : implication de la voie du Glucagon Like Peptide-1 (GLP-1)

Lebrun, L., Nguyen, A. T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D. J., Lagrost, L., & Grober, J. (2014) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(14)70858-1

Endotoxemia and glucose homeostasis

Nguyen, A. T. (2013) · theses.fr (ABES)

P168 Augmentation par les lipopolysaccharides de la sécrétion d’insuline stimulée par le glucose : Implication de la voie du Glucagon Like Peptide-1 (GLP-1)

Grober, J., Nguyen, A., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D. J., & Lagrost, L. (2014) · Diabetes & Metabolism · doi:10.1016/s1262-3636(14)72460-7

The Type of Bacterial Lipopolysaccharides Dictates Insulin Resistance, GLP-1 and Insulin Secretion During Metabolic EndotoxemiaPreprint

Anhê, F. F., Barra, N. G., Cavallari, J. F., & Schertzer, J. D. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3600557